Kounosu, Japan

Shin-ichi Kodato


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Shin-ichi Kodato

Introduction

Shin-ichi Kodato is a notable inventor based in Kounosu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thiazine derivatives. With a total of 3 patents to his name, his work has implications for treating various medical conditions.

Latest Patents

Kodato's latest patents include innovative compounds that exhibit calcium antagonistic activity within cerebral tissues. One of his notable inventions is a thiazine derivative that has potential use in the prophylaxis and treatment of ischemic encephalopathia. Another patent focuses on thiazine derivatives that can be utilized for treating cerebral neurocyte dyscrasia. These compounds are characterized by specific chemical structures that enhance their therapeutic efficacy.

Career Highlights

Kodato is currently employed at Tanabe Seiyaku Company, Limited, where he continues to advance his research in medicinal chemistry. His work has been instrumental in developing new therapeutic agents that address critical health issues. His dedication to innovation in pharmaceuticals has positioned him as a key figure in his field.

Collaborations

Kodato has collaborated with several esteemed colleagues, including Masakatsu Ozeki and Kousuke Yasuda. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Shin-ichi Kodato's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the medical community positively, paving the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…